|
US5795587A
(en)
*
|
1995-01-23 |
1998-08-18 |
University Of Pittsburgh |
Stable lipid-comprising drug delivery complexes and methods for their production
|
|
US6008202A
(en)
*
|
1995-01-23 |
1999-12-28 |
University Of Pittsburgh |
Stable lipid-comprising drug delivery complexes and methods for their production
|
|
US6210707B1
(en)
*
|
1996-11-12 |
2001-04-03 |
The Regents Of The University Of California |
Methods of forming protein-linked lipidic microparticles, and compositions thereof
|
|
PT956001E
(pt)
*
|
1996-11-12 |
2012-12-06 |
Univ California |
Preparação de formulações estáveis de complexos do tipo lípido-ácido nucleico para uma entrega eficiente in vivo
|
|
US6436708B1
(en)
*
|
1997-04-17 |
2002-08-20 |
Paola Leone |
Delivery system for gene therapy to the brain
|
|
US6749863B1
(en)
|
1997-11-19 |
2004-06-15 |
Georgetown University |
Targeted liposome gene delivery
|
|
ATE237312T1
(de)
*
|
1998-07-20 |
2003-05-15 |
Protiva Biotherapeutics Inc |
In liposomen verkapselte nukleinsäurekomplexe
|
|
US7780882B2
(en)
*
|
1999-02-22 |
2010-08-24 |
Georgetown University |
Simplified and improved method for preparing an antibody or an antibody fragment targeted immunoliposome for systemic administration of a therapeutic or diagnostic agent
|
|
EP1811036B8
(en)
*
|
1999-02-22 |
2011-09-21 |
Georgetown University |
Antibody fragment-targeted immunoliposomes for systemic gene delivery
|
|
US9034330B2
(en)
|
1999-02-22 |
2015-05-19 |
Georgetown University |
Preparation of antibody or an antibody fragment-targeted immunoliposomes for systemic administration of therapeutic or diagnostic agents and uses thereof
|
|
US9034329B2
(en)
*
|
1999-02-22 |
2015-05-19 |
Georgetown University |
Preparation of antibody or an antibody fragment-targeted immunoliposomes for systemic administration of therapeutic or diagnostic agents and uses thereof
|
|
ES2295018T3
(es)
*
|
1999-03-02 |
2008-04-16 |
Transave, Inc. |
Encapsulacion de complejos bioactivos en liposomas.
|
|
EP1754488A1
(en)
*
|
1999-05-24 |
2007-02-21 |
Introgen Therapeutics, Inc. |
Methods and compositions for non-viral gene therapy for treatment of hyperproliferative diseases
|
|
CA2371922C
(en)
*
|
1999-05-24 |
2012-03-27 |
Introgen Therapeutics, Inc. |
Methods and compositions for non-viral gene therapy for treatment of hyperproliferative diseases
|
|
US7067111B1
(en)
*
|
1999-10-25 |
2006-06-27 |
Board Of Regents, University Of Texas System |
Ethylenedicysteine (EC)-drug conjugates, compositions and methods for tissue specific disease imaging
|
|
US7189705B2
(en)
*
|
2000-04-20 |
2007-03-13 |
The University Of British Columbia |
Methods of enhancing SPLP-mediated transfection using endosomal membrane destabilizers
|
|
US10293056B1
(en)
|
2000-05-24 |
2019-05-21 |
Board Of Regents, The University Of Texas System |
Methods and compositions for non-viral gene therapy for treatment of hyperproliferative diseases
|
|
IL153218A0
(en)
|
2000-06-02 |
2003-07-06 |
Univ Texas |
Ethylenedicysteine (ec) -drug conjugates
|
|
EP1322337A2
(en)
*
|
2000-09-25 |
2003-07-02 |
Board of Regents, The University of Texas System |
Pei : dna vector formulations for in vitro and in vivo gene delivery
|
|
US20020146829A1
(en)
*
|
2000-11-29 |
2002-10-10 |
Aventis Pharmaceuticals Products Inc. |
Neutral and anionic colloidal particles for gene delivery
|
|
ATE407684T1
(de)
*
|
2001-04-02 |
2008-09-15 |
Univ Georgetown |
Vereinfachtes und verbessertes verfahren zur herstellung eines antikörper- oder antikörperfragment-targeted immunoliposoms oder polyplex für die systemische verabreichung eines therapeutischen oder diagnostischen mittels
|
|
US20020197261A1
(en)
*
|
2001-04-26 |
2002-12-26 |
Chun Li |
Therapeutic agent/ligand conjugate compositions, their methods of synthesis and use
|
|
US20030203865A1
(en)
*
|
2001-04-30 |
2003-10-30 |
Pierrot Harvie |
Lipid-comprising drug delivery complexes and methods for their production
|
|
EP1389182A1
(en)
*
|
2001-05-15 |
2004-02-18 |
Transgene S.A. |
Complexes for transferring substances of interest into a cell
|
|
FR2829136B1
(fr)
*
|
2001-08-29 |
2006-11-17 |
Aventis Pharma Sa |
Derives lipidiques d'aminoglycosides
|
|
US20030049203A1
(en)
*
|
2001-08-31 |
2003-03-13 |
Elmaleh David R. |
Targeted nucleic acid constructs and uses related thereto
|
|
US7261875B2
(en)
*
|
2001-12-21 |
2007-08-28 |
Board Of Regents, The University Of Texas System |
Dendritic poly (amino acid) carriers and methods of use
|
|
KR100466254B1
(ko)
*
|
2002-02-25 |
2005-01-14 |
한국과학기술원 |
세포내 전달을 위한 올리고뉴클레오티드와 친수성 고분자로 구성되는 유전자 전달용 접합체, 고분자 전해질 복합 미셀 및 그의 제조방법
|
|
CA2752143C
(en)
*
|
2002-05-15 |
2014-09-23 |
Sutter West Bay Hospitals |
Delivery of nucleic acid-like compounds
|
|
US20040137064A1
(en)
*
|
2003-01-15 |
2004-07-15 |
Lewis David L. |
Compositions and processes using siRNA, amphipathic compounds and polycations
|
|
JP2005529959A
(ja)
*
|
2002-06-14 |
2005-10-06 |
マイラス コーポレイション |
細胞へのポリヌクレオチドの伝達をするための新規な方法
|
|
CN1723042B
(zh)
*
|
2002-11-07 |
2010-12-01 |
得克萨斯大学体系董事会 |
乙二半胱氨酸(ec)-药物结合物、组合物及用于组织特异性疾病显像的方法
|
|
WO2004064750A2
(en)
|
2003-01-22 |
2004-08-05 |
Duke University |
Improved constructs for expressing lysosomal polypeptides
|
|
US7678540B2
(en)
*
|
2003-10-16 |
2010-03-16 |
University Of Massachusetts |
Template-directed assembly of receptor signaling complexes
|
|
US9050378B2
(en)
*
|
2003-12-10 |
2015-06-09 |
Board Of Regents, The University Of Texas System |
N2S2 chelate-targeting ligand conjugates
|
|
US20050261221A1
(en)
*
|
2004-03-01 |
2005-11-24 |
Li Wang |
Compositions and methods for enhanced delivery of compounds via transfection complexes
|
|
JP2007532573A
(ja)
*
|
2004-04-09 |
2007-11-15 |
バイオデリバリー サイエンシーズ インターナショナル インコーポレイティッド |
ヌクレオチド−渦巻状組成物および使用の方法
|
|
WO2006074108A2
(en)
*
|
2004-12-30 |
2006-07-13 |
Hauser Todd M |
Compositions and methods for modulating gene expression using self-protected oligonucleotides
|
|
KR20070104575A
(ko)
*
|
2005-01-28 |
2007-10-26 |
교와 핫꼬 고교 가부시끼가이샤 |
표적 유전자의 발현을 억제하는 조성물
|
|
JPWO2007080902A1
(ja)
*
|
2006-01-11 |
2009-06-11 |
協和発酵キリン株式会社 |
眼球において標的遺伝子の発現を抑制する組成物および眼球における疾患の治療剤
|
|
JP2009531438A
(ja)
*
|
2006-03-24 |
2009-09-03 |
ジェンシア コーポレイション |
合成脂質ラフトおよび使用方法
|
|
US8758723B2
(en)
|
2006-04-19 |
2014-06-24 |
The Board Of Regents Of The University Of Texas System |
Compositions and methods for cellular imaging and therapy
|
|
PT2019683T
(pt)
*
|
2006-04-25 |
2017-03-17 |
Univ California |
Administração de fatores de crescimento para o tratamento de distúrbios do snc
|
|
EP2023949A4
(en)
*
|
2006-04-26 |
2009-08-26 |
Univ California |
COMPOSITIONS AND METHODS FOR CONVECTION-REINFORCED RELEASE OF NEUROTHERAPEUTICS WITH HIGH MOLECULAR WEIGHT
|
|
EP2049679A4
(en)
*
|
2006-06-28 |
2010-02-24 |
P A Technologies Llc |
METHOD AND MATERIALS FOR IN VITRO ANALYSIS AND / OR USE OF MEMBRANE ASSOCIATED PROTEINS, PARTS THEREOF OR VARIANTS THEREOF
|
|
US20080213349A1
(en)
*
|
2006-09-11 |
2008-09-04 |
Deepak Ramesh Thakker |
Liposome Complexes Containing Pharmaceutical Agents and Methods
|
|
CA2665403C
(en)
*
|
2006-10-04 |
2015-06-23 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
Compositions comprising a sirna and lipidic 4,5-disubstituted 2-deoxystreptamine ring aminoglycoside derivatives and uses thereof
|
|
US10925977B2
(en)
|
2006-10-05 |
2021-02-23 |
Ceil>Point, LLC |
Efficient synthesis of chelators for nuclear imaging and radiotherapy: compositions and applications
|
|
EP2136832B1
(en)
|
2007-03-26 |
2015-09-02 |
General Regeneratives Limited |
Methods for promoting protection and regeneration of bone marrow using cxcl9 and anti-cxcl9 antibodies
|
|
EA201070050A1
(ru)
*
|
2007-07-09 |
2010-10-29 |
Джорджтаун Юниверсити |
Способы индукции иммунного ответа с применением доставки нуклеиновых кислот, опосредованной катионными липосомами
|
|
RU2476204C2
(ru)
*
|
2008-06-19 |
2013-02-27 |
Ниппон Синяку Ко., Лтд. |
Носитель лекарственного средства
|
|
US20110268772A1
(en)
*
|
2008-12-26 |
2011-11-03 |
Samyang Corporation |
Pharmaceutical composition containing an anionic drug and a production method thereof
|
|
TWI540319B
(zh)
|
2010-03-29 |
2016-07-01 |
中央研究院 |
以細胞質譜分析定量細胞所攝入之奈米/微米粒子
|
|
RU2436583C1
(ru)
*
|
2010-07-06 |
2011-12-20 |
Общество с ограниченной ответственностью "ВИТАЛАНГ" |
Противовирусное средство
|
|
JP5760562B2
(ja)
*
|
2011-03-22 |
2015-08-12 |
セイコーエプソン株式会社 |
読取装置および読取方法
|
|
AU2012312520A1
(en)
|
2011-09-20 |
2014-05-08 |
The University Of North Carolina At Chapel Hill |
Regulation of sodium channels by PLUNC proteins
|
|
US9238865B2
(en)
|
2012-02-06 |
2016-01-19 |
Asm Ip Holding B.V. |
Multiple vapor sources for vapor deposition
|
|
WO2016045732A1
(en)
|
2014-09-25 |
2016-03-31 |
Biontech Rna Pharmaceuticals Gmbh |
Stable formulations of lipids and liposomes
|
|
ES2979122T3
(es)
|
2016-02-22 |
2024-09-24 |
Univ North Carolina Chapel Hill |
Inhibidores peptídicos de los canales de calcio
|
|
US11788190B2
(en)
|
2019-07-05 |
2023-10-17 |
Asm Ip Holding B.V. |
Liquid vaporizer
|
|
AU2020311399A1
(en)
*
|
2019-07-10 |
2022-02-17 |
University Of Washington |
Non-viral immuno-targeting
|
|
US11946136B2
(en)
|
2019-09-20 |
2024-04-02 |
Asm Ip Holding B.V. |
Semiconductor processing device
|
|
GB202004254D0
(en)
|
2020-03-24 |
2020-05-06 |
Puridify Ltd |
Characterization of gene therapy vectors
|
|
CA3234346A1
(en)
*
|
2021-09-30 |
2023-04-06 |
Nof Corporation |
Lipid nanoparticles having cell directivity
|
|
DE102023001946A1
(de)
*
|
2023-05-12 |
2024-11-14 |
Friedrich-Schiller-Universität Jena, Körperschaft des öffentlichen Rechts |
Nanopartikel für den Transport von Wirkstoffen mit anionischen Gruppen, Verfahren zu deren Herstellung und deren Verwendung
|
|
CN119490670A
(zh)
*
|
2024-11-26 |
2025-02-21 |
山东大学 |
一种慢病毒转染增强纳米颗粒及其制备方法与应用
|